May 06, 2026 08:03 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jolt to TMC! Supreme Court rejects plea challenging central staff deployment at Bengal counting centres | Bangladesh MP warns of refugee crisis if BJP wins West Bengal polls | Diplomatic row: Bangladesh summons Indian envoy over Himanta Biswa Sarma remarks | Supreme Court grants Pawan Khera anticipatory bail in case over allegations against Himanta Biswa Sarma's wife | ‘Not necessary to humiliate me with arrest’: Pawan Khera to SC over remarks on Himanta Biswa Sarma’s wife | ‘Let’s not choose for people capable of choosing’: Supreme Court to Centre on teen pregnancy termination | I-PAC co-founder Vinesh Chandel gets bail after Bengal polls conclude | Exit Polls Give Bengal to BJP—But One Survey Begs to Differ | Big defence push: Rajnath Singh to hold high-stakes talks with Italy’s Defence Minister | “Voting without fear”: PM Modi hails record turnout in West Bengal polls
Weight loss
Study finds weight loss causes significant muscle loss. Photo: Unsplash

Losing weight? You might be losing muscle faster than you think

| @indiablooms | Apr 18, 2026, at 05:38 pm

A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for Type 2 diabetes and obesity, are associated with high rates of muscle loss relative to the amount of weight lost.

John A. Batsis, MD, an expert on obesity and nutrition at the UNC School of Medicine and the UNC Gillings School of Public Health, published his team’s findings in Annals of Internal Medicine.

“While muscle loss is expected during weight loss, we observed that the proportion of weight loss attributable to muscle was consistently higher than anticipated across studies,” said Batsis. “These findings suggest that the magnitude of muscle loss relative to total weight loss warrants closer attention.”

Batsis and his team advise clinicians to carefully monitor patient’s muscle health when advising intentional weight loss.

The findings underscore a need for muscle evaluations and measurements in clinical trials, as well as more trials geared towards older adults taking semaglutide, tirzepatide, and other similar medications.

“Few current studies include participants older than 60 years, and none focused on adults aged 65 years or older,” said Batsis. “Significant muscle loss can lead to a higher fall risk, so additional trials specifically designed to evaluate aging-related outcomes that include mobility and quality of life are urgently needed.”

The findings were presented by Batsis at the breaking news scientific plenary session “New in Annals of Internal Medicine: Hear it First from the Authors” in San Francisco, California, during the American College of Physicians’ (ACP) Internal Medicine Meeting.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.